GlassScriptPhysician profile
Shawn S Kim
NPI 1326027715
$15,273.09
in general payments reported to CMS, 2019-2025
55 companies · $1,827 in 2025
The $1,827 reported for 2025 was more than what 92% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,519 · 2020: $2,783 · 2021: $2,765 · 2022: $1,989 · 2023: $1,359 · 2024: $2,031 · 2025: $1,827.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,217.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,217.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,381.21 | 2019-2025 | Evenity, Otezla, Repatha |
| Abbvie INC. | $1,298.93 | 2019-2025 | |
| Amarin Pharma, INC. | $1,175.93 | 2019-2023 | |
| Astrazeneca Pharmaceuticals LP | $1,172.42 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Novo Nordisk INC | $994.37 | 2019-2025 | Ozempic, Rybelsus |
| Scilex Pharmaceuticals INC. | $965.17 | 2019-2025 | Ztlido |
| Bayer Healthcare Pharmaceuticals INC. | $742.96 | 2021-2025 | |
| Sanofi-Aventis U.S. LLC | $656.45 | 2019-2023 | |
| Pfizer INC. | $606.38 | 2019-2023 | |
| Lilly USA, LLC | $559.66 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $506.11 | 2019-2025 | Jardiance |
| Astellas Pharma US INC | $448.80 | 2019-2025 | Veozah |
| Gilead Sciences, INC. | $440.83 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $380.74 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $352.43 | 2024-2025 | Gemtesa |
Show all 55 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $291.81 | 2020-2022 | |
| Aimmune Therapeutics, INC. | $283.47 | 2024-2025 | Zenpep |
| Arbor Pharmaceuticals, INC. | $265.69 | 2019-2021 | |
| Ardelyx, INC. | $205.51 | 2023-2025 | Ibsrela |
| Kowa Pharmaceuticals America, INC. | $193.08 | 2019-2024 | Zoryve |
| Nestle Healthcare Nutrition INC. | $190.93 | 2021-2023 | |
| Boston Scientific Corporation | $147.76 | 2025 | Ams 700, General - Pain Management |
| Azurity Pharmaceuticals, INC. | $140.21 | 2023-2025 | Horizant, Edarbi, Horizant |
| Exact Sciences Corporation | $136.43 | 2023-2025 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $134.00 | 2019-2025 | Dificid, Capvaxive, Gardasil 9 |
| Horizon Therapeutics Plc | $125.28 | 2019-2021 | |
| Vivus LLC | $118.06 | 2021-2025 | Pancreaze |
| Abbott Laboratories | $99.14 | 2022-2024 | Freestyle Libre 3 |
| Ibsa Pharma INC. | $96.28 | 2021-2024 | Licart, Tirosint, Tirosint |
| Fujifilm Wako Diagnostics U.S.A. Corporation | $93.89 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $87.98 | 2020-2021 | |
| Glaxosmithkline, LLC. | $83.92 | 2020-2021 | |
| Dexcom, INC. | $81.82 | 2022-2025 | Dexcom G6 Transmitter |
| Sunovion Pharmaceuticals INC. | $78.96 | 2021 | |
| Corcept Therapeutics | $75.66 | 2023-2024 | Korlym |
| Xeris Pharmaceuticals, INC. | $64.53 | 2023-2025 | Gvoke Hypopen, Keveyis |
| Almatica Pharma LLC | $62.20 | 2021 | |
| Radius Health, INC. | $59.18 | 2024 | Tymlos |
| Allergan, INC. | $56.90 | 2019-2021 | |
| Ascend Therapeutics US, LLC | $50.27 | 2020-2021 | |
| Greenwich Biosciences, INC. | $45.16 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $42.08 | 2021-2025 | Xifaxan |
| Corium, LLC | $34.08 | 2023 | Adlarity |
| Tersera Therapeutics LLC | $32.96 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $25.72 | 2019 | |
| Ucb, INC. | $22.35 | 2019 | |
| Biogen, INC. | $22.18 | 2024 | Leqembi |
| Invivyd INC | $21.15 | 2025 | Pemgarda |
| Genentech USA, INC. | $20.49 | 2019 | |
| Embecta Corp. | $19.81 | 2024 | |
| Averitas Pharma INC. | $19.24 | 2024 | Qutenza |
| Esperion Therapeutics, INC. | $16.77 | 2024 | Nexletol |
| Novartis Pharmaceuticals Corporation | $16.54 | 2020 | |
| Intra-Sana Laboratories | $15.58 | 2022 | |
| Linus Health, INC. | $13.63 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shawn Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.